UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NetEase
NTES
|
+$336M |
| 2 |
AbbVie
ABBV
|
+$235M |
| 3 |
VMW
VMware, Inc
VMW
|
+$163M |
| 4 |
T-Mobile US
TMUS
|
+$156M |
| 5 |
Aptiv
APTV
|
+$154M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$570M |
| 2 |
Microsoft
MSFT
|
+$506M |
| 3 |
Apple
AAPL
|
+$394M |
| 4 |
Abbott
ABT
|
+$262M |
| 5 |
Intel
INTC
|
+$244M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.77% |
| 2 | Healthcare | 13.92% |
| 3 | Consumer Discretionary | 13.52% |
| 4 | Financials | 11.89% |
| 5 | Communication Services | 9.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2351
Peabody Energy
BTU
$2.9B
| $192K | ﹤0.01% |
66,686
-21,707
| -25% | -$71.7K |
|
|
STFC
2352
DELISTED
State Auto Financial Corp
STFC
| $191K | ﹤0.01% |
10,728
-4,599
| -30% | -$98.7K |
|
|
CALA
2353
DELISTED
Calithera Biosciences, Inc
CALA
| $191K | ﹤0.01% |
+1,805
| New | +$214K |
|
|
PLYA
2354
DELISTED
Playa Hotels & Resorts
PLYA
| $190K | ﹤0.01% |
52,546
+11,049
| +27% | +$29.9K |
|
2355
Q32 Bio
QTTB
$464M
| $190K | ﹤0.01% |
694
+88
| +15% | +$23.5K |
|
2356
Carriage Services
CSV
$569M
| $189K | ﹤0.01% |
+10,447
| New | +$176K |
|
2357
Tenaris
TS
$26.8B
| $189K | ﹤0.01% |
14,589
| – | – |
|
2358
Griffon
GFF
$4.86B
| $188K | ﹤0.01% |
10,178
-2,579
| -20% | -$42K |
|
2359
Marcus Corp
MCS
$945M
| $187K | ﹤0.01% |
14,109
| – | – |
|
2360
Independent Bank Corp
IBCP
$844M
| $187K | ﹤0.01% |
12,582
| – | – |
|
2361
SM Energy
SM
$6.92B
| $187K | ﹤0.01% |
49,743
-89,662
| -64% | -$293K |
|
2362
Tilray
TLRY
$622M
| $186K | ﹤0.01% |
2,610
+1,080
| +71% | +$87.1K |
|
|
WLL
2363
DELISTED
Whiting Petroleum Corporation
WLL
| $184K | ﹤0.01% |
2,173
-1,766
| -45% | -$138K |
|
|
FFIC
2364
DELISTED
Flushing Financial
FFIC
| $182K | ﹤0.01% |
15,763
| – | – |
|
2365
KRONOS Worldwide
KRO
$989M
| $181K | ﹤0.01% |
17,369
-15,133
| -47% | -$142K |
|
|
VRAY
2366
DELISTED
ViewRay, Inc.
VRAY
| $180K | ﹤0.01% |
80,455
+7,238
| +10% | +$15.4K |
|
2367
Luxfer Holdings
LXFR
$458M
| $178K | ﹤0.01% |
12,600
| – | – |
|
2368
Voyager Therapeutics
VYGR
$198M
| $177K | ﹤0.01% |
14,009
| – | – |
|
2369
Enel Chile
ENIC
$6.28B
| $176K | ﹤0.01% |
46,680
| – | – |
|
|
WTRE
2370
DELISTED
Watford Holdings Ltd. Common Shares
WTRE
| $172K | ﹤0.01% |
10,300
| – | – |
|
2371
Ituran Location and Control
ITRN
$1.05B
| $171K | ﹤0.01% |
+10,662
| New | +$176K |
|
2372
Lands' End
LE
$403M
| $171K | ﹤0.01% |
21,229
-11,488
| -35% | -$82.6K |
|
2373
American Vanguard Corp
AVD
$68.9M
| $167K | ﹤0.01% |
12,155
+2,050
| +20% | +$27.5K |
|
2374
The RealReal
REAL
$1.48B
| $166K | ﹤0.01% |
+13,000
| New | +$155K |
|
|
AKCA
2375
DELISTED
Akcea Therapeutics Inc
AKCA
| $166K | ﹤0.01% |
+12,084
| New | +$186K |
|
Similar funds
UBS AM's Q2 2020 Portfolio in Review
As of Q2 2020, UBS AM held 2,605 positions worth $164B, up 18% from $139B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
UBS AM withdrew a net $6.16B in Q2 2020, closing 142 positions and reducing 1,290 holdings. Its most notable exit was Allergan plc, an estimated $203M position sold in full.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 21% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, UBS AM opened a new position in Otis Worldwide worth $76.5M.
- UBS AM's largest Q2 2020 buy was Otis Worldwide: 1,345,382 shares worth $76.5M.
- UBS AM added most to NetEase in Q2 2020, an estimated $336M increase.
- UBS AM's biggest Q2 2020 reduction was Alibaba, cutting an estimated $570M.
- UBS AM fully exited Allergan plc in Q2 2020, selling an estimated $203M.
- UBS AM's ten largest holdings make up 24% of its $164B portfolio in Q2 2020.
- UBS AM opened 144 new positions and closed 142 in Q2 2020.
- UBS AM's portfolio value rose 18% quarter-over-quarter to $164B.
Based on UBS AM's 13F filing for Q2 2020, filed 14 Aug 2020.